Hemiplegia, Spastic Clinical Trial
Official title:
THE EFFECTS OF SUBTALAR JOINT MOBILIZATION WITH MOVEMENT ON MUSCLE STRENGTH, BALANCE, FUNCTIONAL PERFORMANCE AND GAIT PARAMETERS IN PATIENTS WITH CHRONIC STROKE
Adequate ankle motion for normal gait ranges from 10° to 15° of dorsiflexion passive range of
motion (DF-PROM) to allow the tibia to move over the talus. However, limited ankle mobility
is a common impairment in patients with stroke whose DF-PROM has been shown to be
approximately half of that in healthy subjects. As a result, these patients have impaired
dynamic balance in standing or gait. Mulligan first proposed mobilization with movement (MWM)
as a joint mobilization technique. Talocrural MWM to facilitate DF-ROM is performed by
applying a posteroanterior tibia glide over a fixed talus while the patient actively moves
into a dorsiflexed position while standing. Talocrural MWM has been applied to chronic ankle
instability and has been proven effective in improving DF-PROM and standing balance. Subtalar
MWM to facilitate DF-ROM is performed by bringing foot to dorsiflexion-abduction-eversion by
flexing patient' knee.
The effects of subtalar MWM have not been investigated in patients with stroke. Therefore,
the purpose of the present study is to examine the effects of subtalar MWM on muscle
strength, balance, functional performance, and gait parameters in patients with chronic
stroke.
Neural factors, such as spasticity, or an increase in the sensitivity of the myotatic reflex,
can contribute significantly to calf muscle stiffness. Likewise, non-neural factors, such as
immobilization and age-induced changes in the mechanical properties of muscle and connective
tissue, are known to increase resistance to joint movement and to contribute to the limited
DF-PROM. Both neural and non-neural factors can impair ankle motion, resulting in balance
impairments during standing or gait. Limited DF-PROM can alter foot positioning in weight
bearing, resulting in hyperextension of the knee, and decreased ability to shift the center
of gravity (COG) during standing and gait. A variety of interventions, such as stretching and
joint mobilization, have been attempted to attenuate the effects of limited DF-PROM and to
reduce further deterioration in patients post stroke. Both stretching and joint mobilization
have been proven effective for improving ankle passive range of motion in patients with
stroke; however, there is a limit to the durability of the effect and improvements in
functional ability. For this reason, improvements in joint range of motion (ROM) must be
accompanied by gains in muscle strength to improve functional ability. This is especially
true for patients with hemiplegia who are not capable of weight bearing symmetrically and
require additional training, including repetitive and continuous weight bearing on the
paretic lower limb.
Adequate ankle motion for normal gait ranges from 10° to 15° of dorsiflexion passive range of
motion (DF-PROM) to allow the tibia to move over the talus. However, limited ankle mobility
is a common impairment in patients with stroke whose DF-PROM has been shown to be
approximately half of that in healthy subjects. As a result, these patients have impaired
dynamic balance in standing or gait. Mulligan first proposed mobilization with movement (MWM)
as a joint mobilization technique. Talocrural MWM to facilitate DF-ROM is performed by
applying a posteroanterior tibia glide over a fixed talus while the patient actively moves
into a dorsiflexed position while standing. Talocrural MWM has been applied to chronic ankle
instability and has been proven effective in improving DF-PROM and standing balance. Subtalar
MWM to facilitate DF-ROM is performed by bringing foot to dorsiflexion-abduction-eversion by
flexing patient' knee.
The effects of subtalar MWM have not been investigated in patients with stroke. Therefore,the
purpose of the present study is to examine the effects of subtalar MWM on muscle strength,
balance, functional performance, and gait parameters in patients with chronic stroke.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04113525 -
Transcutaneous Spinal and Peripheral Stimulation and Wrist Robotic Therapy for Patients With Spastic Stroke
|
N/A | |
Completed |
NCT04613661 -
Inter-rater Reliability of the Australian Spasticity Assessment Scale (ASAS) in Post-stroke Spasticity
|
||
Completed |
NCT03321097 -
Condensed and Distributed Robotic Therapy in Spastic Stroke Post Botulinum Toxin Injection
|
N/A | |
Not yet recruiting |
NCT03621423 -
The Use of Ultrasound for Botulinum Toxin Subscapularis Muscle Injection Guidance in Spastic Hemiplegic Shoulder Pain
|
N/A | |
Completed |
NCT03807557 -
Robotic Modified Constraint -Induced Therapy in Patients With Spastic Hemiplegic Stroke Post Botulinum Toxin A Injection
|
N/A | |
Completed |
NCT04939493 -
Use of Rhythmic Auditory Cueing During Bilateral Training of the Upper Extremities in Stroke Patients
|
N/A | |
Recruiting |
NCT05557305 -
Changes in Motor and Cognitive Function on Unilateral Spastic Cerebral Palsy, Associated With Videogame Therapy
|
N/A | |
Completed |
NCT05889026 -
The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity
|
N/A | |
Completed |
NCT01336517 -
Evaluation of the Effect of an Ankle Foot Orthoses for Ambulatory Function
|
N/A | |
Recruiting |
NCT05767437 -
The Effects of Reaching Task Following Selective Trunk Stability Exercise
|
N/A | |
Recruiting |
NCT05683158 -
Compensatory Kinematic Movements in Various Directions After Stroke
|
||
Completed |
NCT04826900 -
Wearable Robotic System and Robotic Mirror Therapy in Spastic Hemiplegia Post Botulinum Toxin Injection
|
N/A |